Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

A rare ovarian tumor that produced testosterone caused a blood clot in the lungs and increased red blood cells in a woman.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Oral contraceptives with cyproterone acetate improved quality of life for women with PCOS more than those with levonorgestrel.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Spironolactone effectively reduces unwanted hair growth in women with hirsutism.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

PRP may improve fertility treatment success but needs more research for safe use.

Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

17b-Estradiol in skin affects hair growth and tumor promotion.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Women with different PCOS types have similar fertility treatment results.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

150 kHz Electromagnetic Radiation seems to reduce the number and size of ovarian cysts in rats with PCOS, with minimal changes in developing follicles.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.